Acetaminophen And Codeine Phosphate Tablet
NDC Package 87441-009-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Acetaminophen And Codeine Phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate.Limitations of UseBecause of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy ( seeWARNINGS), reserve opioid analgesics, including acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. This formulation utilizes a tablet delivery system. Marketed by Unit Dose Solutions, Inc., this product is identified by NDC 87441-009 and is authorized under FDA application ANDA040419.

Identification & Billing

NDC Package Code
87441-009-01
Package Description
30 TABLET in 1 BLISTER PACK
Product Code
87441-009
11-Digit Billing Format
87441000901
RxNorm Crosswalk
  • RxCUI: 993781 - codeine phosphate 30 MG / acetaminophen 300 MG Oral Tablet
  • RxCUI: 993781 - acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet
  • RxCUI: 993781 - APAP 300 MG / codeine phosphate 30 MG Oral Tablet

Clinical Specifications

Proprietary Name
Acetaminophen And Codeine Phosphate
Non-Proprietary Name
Acetaminophen And Codeine Phosphate
Substance Name
Acetaminophen; Codeine Phosphate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate.Limitations of UseBecause of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy ( seeWARNINGS), reserve opioid analgesics, including acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
DEA Schedule
Schedule III (CIII) Substances

Regulatory & Marketing

Labeler Name
Unit Dose Solutions, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA040419
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-04-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87441-009-01 identifies a specific commercial package of 30 tablet in 1 blister pack of Acetaminophen And Codeine Phosphate, a human prescription drug labeled by Unit Dose Solutions, Inc.. This tablet is formulated for oral use and contains acetaminophen; codeine phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Unit Dose Solutions, Inc. on June 04, 2026. The current certification is valid through December 31, 2027.

How is this Unit Dose Solutions, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87441000901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87441-009-01
11-Digit CMS (5-4-2)
87441-0009-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.